US FDA accepts MS drug Lemtrada resubmission for review
US FDA accepts MS drug Lemtrada resubmission for review
The US Food and Drug Administration (FDA) has accepted for review the Genzyme's resubmission of supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A six-month review period has been assigned for the Lemtrada sBLA. Genzyme expects FDA action on the sBLA in the fourth quarter...... Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1808 Views
-
Last post by frodo
-
- 0 Replies
- 1157 Views
-
Last post by NHE
-
- 0 Replies
- 1620 Views
-
Last post by frodo
-
- 0 Replies
- 1142 Views
-
Last post by frodo
-
- 1 Replies
- 1558 Views
-
Last post by frodo
-
- 0 Replies
- 1933 Views
-
Last post by NHE
-
- 0 Replies
- 2188 Views
-
Last post by NHE
-
- 0 Replies
- 985 Views
-
Last post by frodo
-
- 1 Replies
- 1288 Views
-
Last post by NHE